Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 06:40 ET | Source: Research and Markets

ADME Toxicology Testing Market Technologies, Methods, Applications and Competition Analysis 2021-2030 - High-Throughput Screening and AI-Enhanced Methods are Improving Drug Discovery Efficiency

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Global ADME Toxicology Testing Market - Technologies, Methods and Applications" has been added to ResearchAndMarkets.com's offering. The global ADME...
October 15, 2025 09:00 ET | Source: SNS Insider pvt ltd

ADME Toxicology Testing Market Size to Reach USD 14.40 Billion by 2033 Due to the Rising Drug Discovery and Outsourcing to CROs – SNS Insider

Austin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- ADME Toxicology Testing Market Size & Growth Analysis According to SNS Insider, the global ADME Toxicology Testing Market was valued at USD 6.64...
September 30, 2025 04:08 ET | Source: Research and Markets

Specialty CROs Market Research, Industry Trends and Global Forecasts Report 2025-2035: Strong Focus on Preclinical, Biostatistics and Regulatory Services as US Remains Primary Hub

Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "Specialty CROs Market Industry Trends and Global Forecasts to 2035 - Distribution by Target Therapeutic Area, Type of Service and Key Geographical...
September 02, 2025 05:00 ET | Source: OBI Pharma Inc.

OBI Pharma Announces Phase 1/2 Study Initiation for OBI-902, a TROP2 Targeted Antibody-Drug Conjugate Therapy (ADC) in Advanced Solid Tumors

TAIPEI, Taiwan, Sept. 02, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, a clinical-stage oncology company (4174.TWO), today announced the initiation of a Phase 1/2 clinical trial of OBI-902, an antibody-drug...
September 02, 2025 04:15 ET | Source: Hemex AG

Hemex expands Global Clinical Network Alliance to strengthen end-to-end CRO Capabilities

A newly established global alliance integrating specialized expertise in oncology, medical imaging, patient recruitment as well as pharmacokinetics and pharmacodynamics studiesComprehensive access to...
July 21, 2025 04:20 ET | Source: Research and Markets

Bioavailability Enhancement Technologies and Services Market Industry Trends and Global Forecasts to 2035: Bioavailability Sector Set to Reach USD 10.22 Billion by 2035

Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "Bioavailability Enhancement Technologies and Services Market Industry Trends and Global Forecasts to 2035" report has been added to ...
May 27, 2025 09:22 ET | Source: Research and Markets

Thin Film Drug Manufacturing Business Research Report 2025: Market to reach $23.8 Billion by 2030 - Growing Focus on Enhancing Bioavailability and Drug Absorption Strengthens Business

Dublin, May 27, 2025 (GLOBE NEWSWIRE) -- The "Thin Film Drug Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Thin...
May 06, 2025 07:03 ET | Source: Pasithea

Pasithea Therapeutics Reports Positive Pharmacodynamic Results Demonstrating Robust Target Engagement from its Ongoing Phase 1 Clinical Trial of PAS-004

Pasithea Tx' PAS-004 shows up to 91% pERK inhibition in Phase 1 trial; one pancreatic cancer patient sees 4+ months stable disease and tumor shrinkage.
January 24, 2025 04:04 ET | Source: Research and Markets

Biosimulation Market Outlook 2025-2029: Key Trends Include Digital R&D Strategies, Biosimulation for Biomarker Identification, Digital Biomarkers and Endpoints & Advancements in Computational Biology

Dublin, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market Report 2025" has been added to ResearchAndMarkets.com's offering.The biosimulation market size is forecast to see rapid growth in...
January 06, 2025 09:30 ET | Source: Research and Markets

Therapeutic Drug Monitoring Market Research - Global Forecast to 2029: Expanding Therapeutic Fields Broaden Scope for Drug Monitoring Technologies

Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring Market by Product, Technology, Drug Class, Therapeutic Area, Specimen, End User - Global Forecast to 2029" report has been...